poisar

Stock

Geron Corporation GERN

$1.45-5.54%

Overview

GERN market data

Price History

GERN price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.13
Diluted earnings per share over the trailing twelve months.
Beta
0.61
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-33.1%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$1.04 – $2.01
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $1B · P/B 3.73 · P/S 4.92.

Company News

3 captured
Geron shares are trading higher after the company reported better-than-expected Q2 sales results.Benzinga · Aug 5, 2026, 3:01 PM
Geron Q2 EPS $(0.02) Misses $(0.01) Estimate, Sales $57.480M Beat $55.208M EstimateBenzinga · Aug 5, 2026, 11:00 AM
Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative MarketsBenzinga · May 20, 2026, 2:15 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock